免疫检查点 抑制剂诱导的自身免疫血液溶解性贫血 在子宫内膜癌中
Michael Danziger1, Isabella Hermantin2, Fidela Valea1
1Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Zucker School of Medicine at Hofstra/Northwell, Northwell Health, United states.
Gynecologic oncology reports
|April 28, 2025
概括
免疫检查点抑制剂 (ICI) 在子宫内膜癌 (EC) 患者中可能会引起罕见的副作用,如自身免疫血液溶解性贫血 (AIHA). 及时诊断和管理对于这些新型疗法至关重要.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 免疫检查点抑制剂 (ICI) 已经彻底改变了先进和复发性子宫内膜癌 (EC) 治疗.
- 越来越多的ICI使用与罕见不良事件的增加有关.
- 自身免疫血液溶解性贫血 (AIHA) 是一种罕见但严重的副作用.
研究的目的:
- 在接受新辅助化疗和ICI治疗的高级EC患者中报告AIHA病例.
- 突出ICI诱导的罕见副作用的诊断和管理挑战.
- 强调在管理这些毒性方面需要多学科合作.
主要方法:
- 一位患有IVB期血清性子宫内膜癌的患者的病例报告.
- 治疗包括新辅助性碳烯酸,帕克利塔塞尔和达利利马布 (一种ICI).
- 对AIHA的治疗包括住院治疗,输血,类固醇和修复药.
主要成果:
- 患者在第二次新辅助周期后发展出AIHA.
- 贫血在强化治疗后稳定.
- 没有ICI的随后的化疗周期显示出临床反应,并且没有复发AIHA.
结论:
- 这一案例强调了在欧洲共同体识别和管理罕见的ICI诱导毒性的重要性.
- 跨学科的护理对于解决这些复杂的副作用至关重要.
- 意识和及时干预对于妇科瘤学患者的治疗结果至关重要.
相关概念视频
Tumor Immunotherapy
397
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
397
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K


